Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

INSANE: Biotechne - The Real Truth

What to Expect From Bio-Techne's Next Quarterly Earnings Report

Bio-Techne is scheduled to post its fourth-quarter results soon, and analysts project a single-digit earnings decline.

Barchart

The $11 Billion Reason TECH Stock Is Up Today

Bio-Techne stock rallies as Merck announces an agreement to acquire it for $73 per share. But is there any further upside left in TECH shares?

Barchart

Is Bio-Techne Stock Underperforming the S&P 500?

While Bio-Techne stock has underperformed the broader market over the past year, analysts remain moderately bullish about its prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Are Wall Street Analysts Bullish on Bio-Techne Stock?

While Bio-Techne has lagged behind the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Barchart

Bio-Techne Stock: Is Wall Street Bullish or Bearish?

Despite underperforming the broader market and biotechnology industry over the past year, analysts remain strongly bullish on Bio-Techne’s longer-term prospects.

Barchart

Bio-Techne Stock Upgraded As Analyst Flags Attractive Entry Point

RBC Capital on Tuesday upgraded Bio-Techne Corporation (NASDAQ:TECH), noting that recent end-market weakness has over-penalized one of the best assets in the life science and tools (LST) sector, creating an attractive entry point.

Benzinga

Do Wall Street Analysts Like Bio-Techne Stock?

Bio-Techne has notably underperformed the broader market over the past year, and analysts remain cautiously optimistic about the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Is Bio-Techne Corporation Stock Underperforming the S&P 500?

Despite Bio-Techne Corporation’s underperformance relative to the S&P 500 over the past year, analysts maintain a bullish outlook on the stock’s prospects.

Barchart

Bio-Techne Stock Outlook: Is Wall Street Bullish or Bearish?

Despite Bio-Techne's underperformance relative to the broader market over the past year, Wall Street analysts remain bullish on the stock's prospects.

Barchart

Bio-Techne Earnings Preview: What to Expect

Bio-Techne is expected to announce its second-quarter results in the upcoming month, and analysts expect earnings to remain stable, mirroring the year-ago quarter’s results.

Barchart

Are Wall Street Analysts Predicting Bio-Techne Stock Will Climb or Sink?

Bio-Techne has underperformed the broader market over the past year, yet analysts remain bullish on the stock’s prospects.

Barchart

Bio-Techne Stock: Is TECH Underperforming the Healthcare Sector?

Bio-Techne has underperformed the healthcare sector over the past year, yet analysts remain strongly bullish about the stock’s prospects.

Barchart

Is Wall Street Bullish or Bearish on Bio-Techne Stock?

Bio-Techne has underperformed the broader market this year, but Wall Street analysts are optimistic about the stock’s prospects.

Barchart

What to Expect From Bio-Techne’s Next Quarterly Earnings Report

With Bio-Techne gearing up to release its fourth-quarter earnings next month, analysts project a double-digit earnings decline.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

3 High-Quality Small-Cap Stocks That Investors Are Overlooking

Small-cap stocks frequently hold untapped potential. Here are three high-quality small-cap stocks that investors might be overlooking.

Barchart

Stocks Pressured on the Prospect of Higher for Longer Interest Rates

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed down -0.34%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.70%. US stock indexes Wednesday settled mixed. Stock prices whipsawed higher Wednesday afternoon after bond...

Barchart

Markets are Mixed After FOMC

The S&P 500 Index ($SPX ) (SPY ) is down -0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.23%. The market is mixed the FOMC was released this afternoon. Chairman Jerome Powell announce no...

Barchart

Stocks Fluctuate After FOMC Decision

The S&P 500 Index ($SPX ) (SPY ) is up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.65%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.47%. The FOMC was released this afternoon . Chairman Jerome Powell announced no change in the...

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Stocks Mixed Ahead of Today’s FOMC Decision

The S&P 500 Index ($SPX ) (SPY ) this morning is down -0.12%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.31%. US stock indexes this morning are mixed. The broader market is under pressure...

Benzinga

Recap: Bio-Techne Q3 Earnings

Bio-Techne (NASDAQ:TECH) reported its Q3 earnings results on Wednesday, May 4, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Advanced Micro Devices

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.